🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

Recruitingn/aAges 18 Years - anyAllUniversitätsklinikum Hamburg-Eppendorf
NCT03313687 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with cardiogenic shock treated at a tertiary care hospital. Exclusion Criteria: * Age ≤17 years.
💊

What it tests

  • Not listed
📍

Where

1 site
University Heart Center
Hamburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy